Napoleon Maminta
Internal Medicine · Indianapolis, INNPI 1376526855
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $112,282 of the $115,802 with a category attached, or 97.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 76.0% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $27,237 and has fallen 99.6% since, to $116 in 2025. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $452.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$88K
- Shire North American Group Inc$24K
- AbbVie$1K
- Lilly USA, LLC$397
- Nestle Healthcare Nutrition Inc.$356
- Novo Nordisk$317
- plus $1K from 21 others
What the payments were for
- Consulting fees$112,28297%
- Food & beverage$3,5133%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $88,003 |
| Shire North American Group Inc | 12 | $24,328 |
| AbbVie(2 entities) | 92 | $1,302 |
| Lilly USA, LLC | 18 | $397 |
| Nestle Healthcare Nutrition Inc. | 14 | $356 |
| Novo Nordisk | 12 | $317 |
| AstraZeneca | 2 | $133 |
| Collegium Pharmaceutical, Inc. | 8 | $125 |
| Pfizer | 6 | $94 |
| Sunovion Pharmaceuticals Inc. | 3 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $74 |
| Teva Pharmaceuticals USA, Inc. | 5 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $66 |
| Adlon Therapeutics L.p. | 4 | $64 |
| Novartis | 4 | $57 |
| Boehringer Ingelheim | 3 | $48 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Amgen | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 3 | $39 |
| Antares Pharma, Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Eisai Inc. | 2 | $30 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $14 |
| Merck | 1 | $13 |
| Biogen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$115,802 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $31,242 |
| JardianceEmpagliflozin | 21 | $21,836 |
| Emgality PenGalcanezumab-Gnlm | 11 | $7,904 |
| Hydroxyzine Hcl | 12 | $1,004 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 11 | $920 |
| Gabapentin | 45 | $900 |
| Atorvastatin Calcium | 13 | $83 |
| Meloxicam | 28 | $63 |
| Montelukast Sodium | 11 | $61 |
| Rosuvastatin Calcium | 14 | $52 |
| Prednisone | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $317 | $31,24220 claims |
| Boehringer IngelheimJardiance | $48 | $21,83621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Indianapolis
- Raj VuppalanchiIndianapolis$279K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
- Awaneesh KumarIndianapolis$68K
- Justin FieldIndianapolis$49K
- Misty ShieldsIndianapolis$39K
- Volodymyr OliynykIndianapolis$38K
- Sapan BhutaIndianapolis$30K
- Azizullah BeranIndianapolis$29K
- Rachel WesterIndianapolis$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.